Rchr
J-GLOBAL ID:201201098236996402   Update date: Feb. 01, 2024

Yamazaki Yuri

ヤマザキ ユリ | Yamazaki Yuri
Affiliation and department:
Homepage URL  (1): http://kaken.nii.ac.jp/ja/r/70459725
Research field  (1): Pharmaceuticals - chemistry and drug development
Research keywords  (10): チューブリン ,  癌 ,  医薬品化学 ,  分子認識 ,  生体分子 ,  遺伝子読み飛ばし ,  血管内皮細胞障害 ,  プロドラッグ ,  筋ジストロフィー ,  ネガマイシン
Research theme for competitive and other funds  (4):
  • 2011 - 2011 新規微小管作用薬Plinabulinの創薬指向型分子機能研究
  • 2009 - 2010 Chenical biology research using diketopiperazine-based anti-microtubule agent.
  • 2008 - 2010 Study on Medicinal Chemistry, Chemical Biology and Chemical Pharmaceutics of Anticancer Drug Based on the Microtubule Targeting Agents
  • 2008 - 2009 化学療法による遺伝病克服への挑戦:デュシェンヌ型筋ジストロフィーの治療薬の開発
Papers (11):
more...
MISC (3):
Patents (1):
  • Preparation of dehydrophenylahistin analogus for treating vascular proliferation
Education (2):
  • 2005 - 2007 Kyoto Pharmaceutical University
  • 2001 - 2005 Kyoto Pharmaceutical University Pharmaceutical Sciences
Professional career (1):
  • 博士(薬学)
Work history (2):
  • 2011/11 - 現在 Tokyo University of Pharmacy and Life Sciences School of Pharmacy
  • 2007/06 - 2011/10 Tokyo University of Pharmacy and Life Sciences School of Pharmacy
Association Membership(s) (4):
THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  JAPANESE SOCIETY FOR CHEMICAL BIOLOGY ,  THE JAPANESE PEPTIDE SOCIETY ,  THE PHARMACEUTICAL SOCIETY OF JAPAN
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page